Literature DB >> 9047391

Transformation by ras modifies AP1 composition and activity.

F Mechta1, D Lallemand, C M Pfarr, M Yaniv.   

Abstract

The Ras proteins play a central role in regulating cell growth and their mutation can lead to abnormal proliferation. To analyse the potential link betwen AP1 activity, encoded by members of the jun and fos gene families, and Ras-mediated cellular transformation, we have studied several NIH3T3 clones which overexpress the Ha-Ras or Ki-Ras oncogenes. These transformed fibroblasts accumulated higher levels of cJun, JunB, Fra1 and Fra2 proteins relative to their normal counterparts. They also displayed increased AP1 DNA binding activity which was predominantly composed of cJun and Fra1 containing dimers. Following serum stimulation of Ras clones, the elevated levels of cJun and Fral remained steady, while the induction of JunB and Fra2 was partially attenuated. Moreover, deregulated Ras signaling resulted in a complete loss of the serum inducibility of cFos and FosB. Ectopic co-expression of cJun and Fra1 in NIH3T3 fibroblasts led to a transformed phenotype, attenuation of cFos serum inducibility, increased AP1 activity and Cyclin D1 accumulation, all characteristics of oncogenic Ras expressing cells. These results demonstrate that cJun and Fra1 are crucial mediators of the Ras-transformation process.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9047391     DOI: 10.1038/sj.onc.1200900

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  64 in total

Review 1.  Multiple endocrine neoplasia type 1.

Authors:  M L Brandi
Journal:  Rev Endocr Metab Disord       Date:  2000-11       Impact factor: 6.514

2.  JunB potentiates function of BRCA1 activation domain 1 (AD1) through a coiled-coil-mediated interaction.

Authors:  Yan-Fen Hu; Rong Li
Journal:  Genes Dev       Date:  2002-06-15       Impact factor: 11.361

3.  An extracellular signal-regulated kinase 1- and 2-dependent program of chromatin trafficking of c-Fos and Fra-1 is required for cyclin D1 expression during cell cycle reentry.

Authors:  Peter M Burch; Ziqiang Yuan; Anne Loonen; Nicholas H Heintz
Journal:  Mol Cell Biol       Date:  2004-06       Impact factor: 4.272

4.  Nm23-H1 can induce cell cycle arrest and apoptosis in B cells.

Authors:  Tathagata Choudhuri; Masanao Murakami; Rajeev Kaul; Sushil K Sahu; Suchitra Mohanty; Subhash C Verma; Pankaj Kumar; Erle S Robertson
Journal:  Cancer Biol Ther       Date:  2010-06-11       Impact factor: 4.742

5.  Role of MSK1 in the malignant phenotype of Ras-transformed mouse fibroblasts.

Authors:  Beatriz Pérez-Cadahía; Bojan Drobic; Paula S Espino; Shihua He; Soma Mandal; Shannon Healy; James R Davie
Journal:  J Biol Chem       Date:  2010-11-10       Impact factor: 5.157

6.  The PKCθ pathway participates in the aberrant accumulation of Fra-1 protein in invasive ER-negative breast cancer cells.

Authors:  K Belguise; S Milord; F Galtier; G Moquet-Torcy; M Piechaczyk; D Chalbos
Journal:  Oncogene       Date:  2012-01-30       Impact factor: 9.867

7.  Kaposi's sarcoma-associated herpesvirus induction of AP-1 and interleukin 6 during primary infection mediated by multiple mitogen-activated protein kinase pathways.

Authors:  Jianping Xie; Hongyi Pan; Seungmin Yoo; Shou-Jiang Gao
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

8.  Ubiquitin-independent proteasomal degradation of Fra-1 is antagonized by Erk1/2 pathway-mediated phosphorylation of a unique C-terminal destabilizer.

Authors:  Jihane Basbous; Dany Chalbos; Robert Hipskind; Isabelle Jariel-Encontre; Marc Piechaczyk
Journal:  Mol Cell Biol       Date:  2007-03-19       Impact factor: 4.272

9.  Neoplastic transformation of rat thyroid cells requires the junB and fra-1 gene induction which is dependent on the HMGI-C gene product.

Authors:  D Vallone; S Battista; G M Pierantoni; M Fedele; L Casalino; M Santoro; G Viglietto; A Fusco; P Verde
Journal:  EMBO J       Date:  1997-09-01       Impact factor: 11.598

10.  Radiation-induced acid ceramidase confers prostate cancer resistance and tumor relapse.

Authors:  Joseph C Cheng; Aiping Bai; Thomas H Beckham; S Tucker Marrison; Caroline L Yount; Katherine Young; Ping Lu; Anne M Bartlett; Bill X Wu; Barry J Keane; Kent E Armeson; David T Marshall; Thomas E Keane; Michael T Smith; E Ellen Jones; Richard R Drake; Alicja Bielawska; James S Norris; Xiang Liu
Journal:  J Clin Invest       Date:  2013-09-16       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.